The current study aimed to investigate the effects of prenatal melatonin “MLT” administration against bisphenol A “BPA”- induced infertility and thyroid dysfunction in male rat offsprings (First generation “F1”). For that purpose, fifty adult albino rats (40 females and 10 males) were used and classified equally into five groups (8 females and 2 males in each group). First group (control group) in which, pregnant rats were injected with 0.3 ml of vehicle /day. The second group (low dose BPA) where rats received a daily dose of 25 µg / kg B.W. The third group (high dose BPA) where rats received a daily dose of 250 µg / kg B.W. Fourth group (low dose BPA + MLT) where rats received a daily dose of 25 µg BPA /kg B.W. plus 10 mg MLT / Kg B.W. The fifth group (high dose BPA + MLT) where the rats received a daily dose of 250 µg BPA / kg B.W. plus 10 mg /Kg B.W. All rats within each group received their specific treatment daily with subcutaneous injection starting from the fourth day of pregnancy till full term. Then, the male offsprings of each group were selected and reared until the 60th day after birth. Serum and tissue samples were collected for analyses and microscopical examination. Although prenatal administration of both BPA doses didn’t affect the body weight gain and testicular weights of male offsprings, they reduced significantly the serum levels of testosterone and triodotyrosine when compared to the control group. Also, both BPA doses disturb significantly the oxidant/antioxidant ratio. Moreover, prenatal administration of both BPA doses affected negatively semen quality of the produced offsprings and induced marked histological alterations in their testes and prostate. Remarkably, all serological and histological alterations observed after BPA exposure were ameliorated significantly with MLT co-administration. Thus, prenatal MLT administration could be considered an optimal treatment to relieve many reproductive disorders, degenerative changes of testes and prostate and thyroid malfunction induced in male offsprings after gestational exposure of their dams to BPA.

Butorphanol is a synthetic opioid commonly used for epidural anesthesia in human either alone or in combination with bupivacaine but not in goat. The objective of the present study was to evaluate the analgesic effect of epidural butorphanol either alone or in combination with bupivacaine. Fifteen adult apparently healthy goats were randomized into three equal groups to receive a lumbosacral epidural injection of bupivacaine 0.5 % (0.5 mg/kg), butorphanol 1% (0.08 mg/kg) or their combination (bupivacaine 0.25 mg/kg and butorphanol 0.04 mg/kg). Animals were observed for incoordination of hind limbs, perineal pin prick and sedation at 10 minutes interval. Heart rate, respiratory rate and rectal temperature were assessed every 15 minutes. Epidural butorphanol resulted into significantly (P <0.05) rapid analgesia (9.8 ± 1.1 Min) than the butorphanol– bupivacaine combination (12.8 ± 0.84 Min) and bupivacaine (16.6 ± 0.55). Butorphanolbupivacaine combination provoked significant ((P < 0.05) prolonged intense analgesia (208 ± 8.36 Min) compared to either bupivacaine (112 ± 8.37) or butorphanol (166 ± 5.48 Min). Ataxia accompanied administration of bupivacaine either alone or in combination with butorphanol, while sedation was observed in animals received butorphanol alone or combined with bupivacaine. No significant changes were observed in heart rate, respiratory rate or rectal temperature. The epidural administration of butorphanol-bupivacaine combination promoted longer-lasting analgesia in goats without motor disturbances compared to bupivacaine alone. This combination might prove useful clinically to provide analgesia in goats for long-duration perineal obstetrical or surgical procedures.

Commercial broiler chickens are frequently infected with Ecoli serotypes in form of collibacillosis which characterized as an initial respiratory infection (air sacculitis) followed by generalized septicemia, perihepatitis and pericarditis. The present work aimed to study the ability of E.coli O125 previuosly isolated and identified from diseased broilers suffered from pericarditis , airsacculitis and perihapatitis to induce a disease and The current study aimed to determine the pathogenicity of E. coli serogroup O125 in broiler chicks, a trial of prevention and treatment using probiotic ( Guardyazin-m) or antibiotic (Cipronate20%). The chicks were divided into seven groups including control negative, orally infected , subcutenously infected , probiotic treated group, and finally antibiotic treated group. The clinical signs, mortality, performance parameters and postmortem examination as well as the pathological changes in liver and intestine were recorded. The probiotic group gave the best results in controlling infection by E. coli O125 followed by antibiotic. In conclusion, the E. coli O125 serogroup was pathogenic to chicks when experimentally inoculated, so particular attention must be directed toward E. coli O125 as a pathogen infecting bird. Also probiotics was of great value in protection against the E. coli infection and improve the performance parameters of chicks . Its effect on feed consumption , weekly body weight gain and feed conversion rate (FCR) was determined.

Acute upper respiratory disease in chickens is a major cause of economic losses due to high mortality rates especially in poorly managed cases. Respiratory disease in poultry is initiated by variety of viruses, bacteria and fungi. The current study aims to investigate the prevalence of avian pathogenic E. coli (APEC), their proteases and other virulence genes in respiratory viral disease outbreaks in broiler chickens. Quantitative RT-PCR (qRT-PCR) was performed on samples from 25 farms with respiratory affections, APEC was isolated and virulence determinants in E. coli were investigated phenotypically and genotypically. E. coli was isolated from different flocks (100%, n=25). They were positive to Congo red binding (100%, n=25), iss gene (100%, n=25), iutA gene (92%, n= 23), tsh gene (24%, n=6), vat gene (20%, n=5). Presence of iss gene and CR binding proves that all isolates are APEC. Although the entire 25 APEC isolates carried more than one virulence gene; either 2 genes (n=17), 3 genes (n=7) and 4 genes (n=1), no effect of the number of genes harbored on the mortality rates in different flocks was observed. The presence of two serine proteases genes (tsh and vat) was confirmed in a total of 10 isolates (40% of the isolates) with positivity to tsh gene (24%) and vat gene (20%). qRT-PCR for detection of IBV-S1, AIV-H9, AIV-H5 and velogenic NDV-F genes revealed that 96% (n=24), 44% (n=11), 12% (n=3) and 4% (n=1) of 25 farms were positive to IBV, AIV-H9, velogenic NDV and AIV-H5, respectively. The results showed that among the 25 flocks, single viral infection was observed in 12 flocks (11 IBV and 1 AIV-H9), while mixed viral infections were detected in 13 flocks; IBV/AIV-H9 (n=9), IBV/velogenic NDV (n=3) and IBV/AIV-H9/AIV-H5 (n=1).The average mortality rate was the lowest in flocks infected with IBV, higher rates of mortality were observed in flocks infected with AIV-H9, velogenic NDV and AIV-H5. Flock age seems to affect the mortality rate in flocks infected with AIV-H9 where flocks aging 16:20, 21:25 and 26:30 days suffered from 2.38%, 8.13%, 11.48% average mortality rates, respectively.

Vaccination of domestic ruminants is considered to be an effective strategy for protecting these animals against Rift Valley fever (RVF), but available vaccines have limitations. Therefore, the aim of this study was to determine the safety and immunogenicity of RVF virus (RVFV) mutagenesis passage 12 (MP-12) and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) in Tanzania. Goats were vaccinated intramuscularly with RVFV MP-12 or arMP-12ΔNSm21/384, and then on Day 87 post-vaccination (PV) all animals were revaccinated using the RVFV MP-12 vaccine candidate. Serum samples were collected from the animals before and after vaccination at various intervals to test for RVFV using a Vero cell culture assay and reverse transcription polymerase chain reaction and for RVFV-neutralising antibody using a plaque reduction neutralisation assay. Serum samples collected before vaccination on Days -14 and 0, and on Days 3, 4 and 5 PV were negative for RVFV and neutralising antibody. All animals remained healthy, and viremia was not detected in any of the animals. Rift Valley fever virus antibody was first detected on Day 5 PV at a 1:10 dilution in five of five animals vaccinated with the MP-12 vaccine and in five of eight animals vaccinated with arMP-12ΔNSm21/384. Titres then increased and were sustained at 1:40 to 1:640 through to Day 87 PV. All animals that were revaccinated on Day 87 PV with MP-12 developed antibody titres ranging from 1:160 to as high as 1:10 240 on Days 14 and 21 PV. Although the antibody titres for goats vaccinated with RVF MP-12 were slightly higher than titres elicited by the arMP-12ΔNSm21/384 vaccine, these findings demonstrated that both vaccines are promising candidates for the prevention of RVF among Tansanian goats.

Bovine respiratory disease (BRD) is the most common and costly disease affecting beef cattle calves in the world. The objectives of this study were to put a high light on epidemiology of P. multocida and M. haemolytica as important causes of bovine respiratory disease (BRD) in Egypt Governorates; Giza, El-Fayoum, BeniSuef, Assiut and Sohag. A total number of 406 deep nasal swabs and blood samples were collected from 406 bovine calves suffered from respiratory manifestations reared in different Governorates in Egypt. Bacteriological examination was achieved and isolation of P. multocida and M. haemolytica were attained. The overall prevalence of both P. multocida and M. haemolytica was of 26.6%; 18.2% for P. multocida and 8.4%for M. haemolytica. EL-Fayoum Governorate showed the highest prevalences while Beni-Suef Governorate showed the lowest prevalences. P. multocida was singly isolated from 4.9% of cases. While it was mixed with S. aureus, E. coli, Streptococcus spp., both S. aureus and E. coli, both S. aureus and Streptococcus spp. and both E. coli and Streptococcus spp. with percentages of 4%, 1.2%, 2.2%, 1.7%, 3.2% and 1.0%, respectively. Meanwhile, M. haemolytica was isolated as a single isolate from 1.7% of cases while it was mixed with S.aureus, Streptococcus spp., both S. aureus and Streptococcus spp. and both E. coli and Streptococcus spp. with percentages of 2.7%, 1.2%, 2.5% and 0.2%, respectively. In conclusion respiratory manifestations are very important disorders in bovine calves. P. multocida and M. haemolytica are the most common bacteria causing infection.

OBJECTIVE To evaluate lameness and morphological changes associated with an osteochondral fragment–groove procedure as a means of experimental induction of metacarpophalangeal (MCP) joint osteoarthritis within an 11-week period in horses. ANIMALS 6 nonlame adult warmbloods. PROCEDURES The right MCP joint of each horse underwent an osteochondral fragment–groove procedure (day 0). After 1 week of stall rest (ie, starting day 7), each horse was trained daily on a treadmill. Weekly, horses underwent visual and inertial sensor-based assessments of lameness. Both MCP joints were assessed radiographically on days 0 (before surgery), 1, 35, and 77. A synovial fluid sample was collected from the right MCP joint on days 0 (before surgery), 35, 36, 49, 63, and 77 for cytologic and biomarker analyses. On day 77, each horse was euthanized; both MCP joints were evaluated macroscopically and histologically. RESULTS Right forelimb lameness was detected visually and by the inertial sensor system when horses were moving on a straight line after distal forelimb flexion or circling left on days 14 to 77. Compared with presurgical values, synovial fluid interleukin-6, prostaglandin E2, hyaluronic acid, and interleukin-1 receptor antagonist protein concentrations were increased at 2 or 3 time points, whereas tumor necrosis factor-α and interleukin-10 concentrations were decreased at 1 time point. Gross examination of all right MCP joints revealed synovitis and wear lines; synovitis was confirmed histologically. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that a combined osteochondral fragment–groove procedure can be used to induce clinically and grossly observable early MCP joint osteoarthritis during an 11-week period in horses.